Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Eur J Endocrinol. 2020 Jul;183(1):63–71. doi: 10.1530/EJE-20-0129

Table 3:

Comparison between patients with nonclassic 21-hydroxylase deficiency (N21OHD) and controls of the same sex

Females Males
N21OHD (n=25) Controls (n=47) Ratio* P N21OHD (n=7) Controls (n=7) Ratio* P
Age (years) 27 [18–34] 28 [21–36] 0.696 9 [8–13] 18 [12–52] 0.036
BMI (kg/m2) 26 [22–32] 28 [23–33] 0.224 21 [19–26] 26 [15–31] 0.62
17OHP4 (nmol/L) 16.8 [8.1–55.7] 2.3[1–4] 7.4 <0.0001 24.9 [13.6–55.7] 2.8 [2.1–3.8] 9.0 0.0006
16OHP4 (nmol/L) 2.3 [1–7.7] 0.6 [0.3–0.9] 4.1 <0.0001 2.8 [1.5–7.7] 0.6 [0.5–0.9] 5.0 0.002
21dF (nmol/L) 1.8 [1.2–5.1] 0.0 [0.0–0.0] N/A <0.0001 1.5 [1.3–5.1] 0.0 [0.0–0.5] N/A 0.0006
Progesterone (nmol/L) 0.8 [0.4–1.5] 0.4 [0.3–0.8] 1.8 0.014 1.0 [0.5–1.5] 0.4 [0.3–0.8] 2.2 0.052
Cortisol (nmol/L) 233.4 [128.1–555] 256.0 [206.6–423.6] 0.9 0.429 189.7 [81.4–222.1] 219.0 [129.4–245.4] 0.9 0.318
Cortisone (nmol/L) 57 [31.2–64.2] 52.5 [44.6–63.7] 1.1 0.823 50.4 [23.4–64.2] 39.4 [20.6–52.9] 1.3 0.710
Corticosterone (nmol/L) 2.0 [0.8–1.7] 5.4 [3.3–15.3] 0.4 <0.0001 1.4 [0.5–1.7] 5.0 [3.3–14.7] 0.3 0.0006
11dF (nmol/L) 0.8 [0.5–1.4] 0.6 [0.4–1.4] 1.2 0.482 1.1 [0.6–1.4] 1.1 [0.6–1.6] 1.0 0.477
DOC (nmol/L) 0.3 [0.3–0.4] 0.4 [0.2–0.7] 0.8 0.322 0.3 [0.3–0.4] 0.6 [0.5–0.8] 0.5 0.001
A4 (nmol/L) 4.7 [2.6–3.4] 4.8 [3.1–7.1] 1.0 0.890 1.9 [0.6–3.4] 2.1 [1.0–2.4] 0.9 0.901
T (nmol/L) 1.2 [0.8–11.2] 1.2 [0.9–2.8] 1.0 0.696 0.4 [0.2–11.2] 9.4 [0.6–16] 0.04 0.137
11OHA4 (nmol/L) 10.1 [5.8–28.4] 4.4 [2.9–7.3] 2.3 <0.0001 5.4 [3.1–28.4] 4.2 [1.6–5.3] 1.3 0.318
11KA4 (nmol/L) 1.3 [0.7–1.4] 0.6 [0.5–0.8] 2.1 0.0003 0.9 [0.4–1.4] 0.6 [0.3–0.8] 1.4 0.105
11OHT (nmol/L) 1.1 [0.5–0.5] 0.4 [0.3–0.6] 2.6 <0.0001 0.3 [0.2–0.5] 0.3 [0.1–0.4] 1.1 0.685
11KT (nmol/L) 2.4 [1.4–2.3] 0.8 [0.6–1.3] 2.9 <0.0001 1.4 [0.9–2.3] 0.4 [0.3–1.0] 3.2 0.024

Data are expressed as median [interquartile range]. 17OHP4, 17α-hydroxyprogesterone; 16OHP4, 16α-hydroxyprogesterone; 21dF, 21-deoxycortisol; 11dF, 11-deoxycortisol; DOC, 11-deoxycorticosterone; A4, androstenedione; T, testosterone; 11OHA4, 11β-hydroxyandrostenedione; 11KA4, 11-ketoandrostenedione; 11OHT 11β-hydroxytestosterone; 11KT, 11-ketotestosterone; F, females; M, males.

*

Ratio of medians N21OHD/Controls